Amikacin Sulfate Injection, Solution
Product Images NDC 63323-815

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amikacin Sulfate (NDC 63323-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ami0b 0000 01

Chemical structure of Amikacin Sulfate. The diagram shows the molecular arrangement with multiple sugar rings, amino groups, and sulfate moieties representing the dihydrate form of amikacin sulfate.*

FDA Label Image

Ami0b 0000 02

FDA Label Image

Ami0b 0000 03

Label for Amikacin Sulfate Injection USP, 500 mg per 2 mL (250 mg/mL) solution for intramuscular or intravenous use. The 2 mL single-dose vial label includes dosage instructions, storage conditions, and the labeler Fresenius Kabi USA, LLC, with the product NDC 63323-8152.*

FDA Label Image

Ami0b 0000 04

Amikacin Sulfate Injection, USP label showing the strength as 500 mg per 2 mL solution (equivalent to 250 mg per mL). The label indicates it is for intramuscular or intravenous use. The label also includes the product NDC code 63323-815-02 and is from Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.